Engineered Reverse Transcriptases for Inhibitor-Tolerant DNA Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing reverse transcriptases (RTs) are inefficient in the presence of substances commonly found in medical and environmental samples, leading to reduced DNA synthesis and potential false positive results in PCR tests.
Innovation Solution
Development of engineered RTs with improved efficiency and tolerance to inhibitors such as salts, chemicals, and sample components, featuring specific amino acid sequences and potential fusion proteins with enhanced activity and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If naturally occurring RTs or conventional engineered RTs are used, then the RT can synthesize DNA under standard conditions, but the RT efficiency is reduced in the presence of salts and substances found in medical and environmental samples
Solution Approach 1:
The patent applies parameter changes by modifying the amino acid sequence of the reverse transcriptase enzyme to alter its biochemical properties. Specifically, the engineered RT contains amino acid substitutions that change its interaction with inhibitory substances, allowing it to maintain catalytic activity in the presence of salts and sample constituents that would inhibit conventional RTs. This direct modification of enzyme parameters resolves the contradiction between maintaining RT efficiency and resisting inhibition.
2Adaptability or versatility
If RTs are used in complex samples containing inhibitors, then the RT can process real-world samples, but the DNA synthesis amount is reduced and false positive results occur
Solution Approach 1:
The engineered reverse transcriptase uses amino acid sequence modifications to change its functional parameters, specifically its tolerance to inhibitory substances. This allows the enzyme to maintain reliable DNA synthesis in complex samples containing salts and other constituents, thereby achieving both adaptability to challenging conditions and precision in PCR results without the false positives associated with conventional RTs.
3Ease of operation
If conventional RTs are used, then the enzyme can function in standard buffer conditions, but the enzyme activity is inhibited by substances present in medical and environmental samples
Solution Approach 1:
The patent modifies the biochemical parameters of the reverse transcriptase through amino acid engineering. The engineered enzyme maintains ease of operation by retaining DNA synthesis activity while simultaneously resisting inhibition from substances in medical and environmental samples, resolving the contradiction between operational ease and resistance to harmful factors.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered RTs maintain high efficiency in synthesizing DNA under challenging conditions, reducing false positive results and improving PCR test accuracy.
Implementation Method 1
reverse transcriptases (RTs) are multi-functional enzymes that typically have multiple enzymatic activities, including an RNA-dependent DNA polymerization activity
Implementation Method 2
a DNA-dependent DNA polymerization activity
Implementation Method 3
an RNaseH activity that catalyzes the cleavage of RNA in RNA-DNA hybrids
Data Source
AI summary
Reverse transcriptases that may have an improvement in one or more properties are provided. For example, the present reverse transcriptases are believed to be more efficient than other reverse transcriptases, particularly in the presence of substances that typically inhibit reverse transcriptases. Also provided are related compositions, kits, and methods for using the reverse transcriptases.